Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD-Reference-Cited by-同舟云学术

Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD

Published:2023-01 Issue:1 Volume:29 Page:44.e1-44.e9
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Claveau Jean-Sébastien^ORCID,LeBlanc Richard^ORCID,Ahmad Imran^ORCID,Delisle Jean-Sébastien^ORCID,Cohen Sandra,Kiss Thomas,Bambace Nadia M.,Bernard Léa,Lachance Silvy^ORCID,Roy Denis Claude,Sauvageau Guy^ORCID,Veilleux Olivier,Roy Jean

Funder

Fonds de Recherche du Québec - Santé

Université de Montréal

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference44 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020

2. Trends in overall survival and costs of multiple myeloma, 2000-2014;Fonseca;Leukemia,2017

3. When to recommend allogeneic transplant in multiple myeloma;Gertz;Leuk Lymphoma,2015

4. Allogeneic transplantation in multiple myeloma—does it still have a place?;Gahrton;J Clin Med,2020

5. Recognizing and managing chronic graft-versus-host disease;Lee;Hematology Am Soc Hematol Educ Program,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years;Frontiers in Oncology;2024-07-31

2. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?;Frontiers in Oncology;2024-06-04